Abstract:MicroRNA (miR)-221 plays an essential role in the epithelial-mesenchymal transition (EMT). High mobility group AT-hook 2 (HMGA2), is a key regulator of EMT. However, the role of miR‑221 in pulmonary fibrosis, and the association between miR‑221 and HMGA2 remain largely unknown. For this purpose, we examined the expression of miR‑221 and HMGA2 in human idiopathic pulmonary fibrosis (IPF) tissues and pulmonary cells, namely the adenocarcinoma A549 and human bronchial epithelium (HBE) cell lines, and found that the expression of miR‑221 was inhibited in both tissues and cells whereas high mRNA and protein expression of HMGA2 was observed. Additionally, transforming growth factor‑β1 (TGF‑β1) induced the EMT, characterized by the upregulated expression of the mesenchymal markers, namely N‑cadherin, vimentin, α‑smooth muscle actin, collagen I and collagen III, and the downregulated expression of the epithelial marker E-cadherin in A549 and HBE cells. We then performed transfection with miR‑221 mimics, and found that the expression of phosphorylated-Smad3 in miR‑221‑overexpressing cells was significantly downregulated, compared with that in the TGF‑β1-treated cells without transfection. Furthermore, the overexpression of miR‑221 decreased the expression of HMGA2, suppressed the EMT, and inhibited the proliferation of A549 and HBE cells. HMGA2 was directly targeted by miR‑221 which was confirmed by the dual-luciferase reporter gene assay. Finally, a mouse model of bleomycin (BLM)‑induced pulmonary fibrosis was used to confirm the effect of miR‑221 on EMT. Hematoxylin and eosin staining showed that BLM induced thicker alveolar walls and more collagen deposition, whereas miR‑221 treatment reduced lung fibrosis and the tissues exhibited thinner alveolar walls and normal lung alveoli. Furthermore, the EMT process was suppressed following miR‑221 injection. Taken together, these findings sugest that miR‑221 targets HMGA2 to inhibit BLM‑induced pulmonary fibrosis through the TGF‑β1/Smad3 signaling pathway.

MicroRNA-411-3p inhibits bleomycin-induced skin fibrosis by regulating transforming growth factor-/Smad ubiquitin regulatory factor-2 signalling

MicroRNA-27a-3p Inhibits Lung and Skin Fibrosis of Systemic Sclerosis by Negatively Regulating SPP1.

Mir-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice

MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition.

MiR-34 B-5 P Knockdown Attenuates Bleomycin-Induced Pulmonary Fibrosis by Targeting Tissue Inhibitor of Metalloproteinase 3 ( TIMP 3 )

Exosomes derived from miR-16-5p-overexpressing keratinocytes attenuates bleomycin-induced skin fibrosis

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29.

Mir-192 Mediates TGF-beta/Smad3-driven Renal Fibrosis.

Mir-301A Suppression Within Fibroblasts Limits the Progression of Fibrosis Through the TSC1/mTOR Pathway

microRNA-142-3p inhibits apoptosis and inflammation induced by bleomycin through down-regulation of Cox-2 in MLE-12 cells

Mir‑221 Targets HMGA2 to Inhibit Bleomycin‑induced Pulmonary Fibrosis by Regulating TGF‑β1/Smad3-induced EMT.

Microrna-21 in Scleroderma Fibrosis and Its Function in Tgf-Beta- Regulated Fibrosis-Related Genes Expression

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

MicroRNA-27a-3p is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation

Mir-24 and Mir-122 Negatively Regulate the Transforming Growth Factor-β/Smad Signaling Pathway in Skeletal Muscle Fibrosis

MicroRNA‐448 overexpression inhibits fibroblast proliferation and collagen synthesis and promotes cell apoptosis via targeting ABCC3 through the JNK signaling pathway

Mir-3606-3p Alleviates Skin Fibrosis by Suppressing Fibroblast Inflammation and Migration Via Inhibiting GAB1 and ITGAV

Unraveling the role of MiR-181 in skin fibrosis pathogenesis by targeting NUDT21

The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis

miR-205 Suppresses Pulmonary Fibrosis By Targeting GATA3 Through Inhibition Of Endoplasmic Reticulum Stress.

Mmu-Microrna-92a-3p Attenuates Pulmonary Fibrosis by Modulating Cpeb4-mediated Smad2/3 Signaling Pathway